CO7061084A2 - Formas sólidas que comprenden inhibidores de ns5a de hcv, sus composiciones y sus usos - Google Patents

Formas sólidas que comprenden inhibidores de ns5a de hcv, sus composiciones y sus usos

Info

Publication number
CO7061084A2
CO7061084A2 CO14201398A CO14201398A CO7061084A2 CO 7061084 A2 CO7061084 A2 CO 7061084A2 CO 14201398 A CO14201398 A CO 14201398A CO 14201398 A CO14201398 A CO 14201398A CO 7061084 A2 CO7061084 A2 CO 7061084A2
Authority
CO
Colombia
Prior art keywords
compositions
solid forms
hcv ns5a
ns5a inhibitors
inhibitors
Prior art date
Application number
CO14201398A
Other languages
English (en)
Inventor
Keith Lorimer
Leping Li
Anna Muchnik
Original Assignee
Presidio Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Presidio Pharmaceuticals Inc filed Critical Presidio Pharmaceuticals Inc
Publication of CO7061084A2 publication Critical patent/CO7061084A2/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/14Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing three or more hetero rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/14Antivirals for RNA viruses
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07BGENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00Indexing scheme relating to specific properties of organic compounds
    • C07B2200/13Crystalline forms, e.g. polymorphs

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Communicable Diseases (AREA)
  • Molecular Biology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Oncology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicinal Preparation (AREA)
CO14201398A 2012-02-13 2014-09-11 Formas sólidas que comprenden inhibidores de ns5a de hcv, sus composiciones y sus usos CO7061084A2 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US201261598249P 2012-02-13 2012-02-13

Publications (1)

Publication Number Publication Date
CO7061084A2 true CO7061084A2 (es) 2014-09-19

Family

ID=48984669

Family Applications (1)

Application Number Title Priority Date Filing Date
CO14201398A CO7061084A2 (es) 2012-02-13 2014-09-11 Formas sólidas que comprenden inhibidores de ns5a de hcv, sus composiciones y sus usos

Country Status (21)

Country Link
US (1) US20150203474A1 (es)
EP (1) EP2814322A4 (es)
JP (1) JP2015506987A (es)
KR (1) KR20140145126A (es)
CN (1) CN104219953A (es)
AR (1) AR093738A1 (es)
AU (1) AU2013221613A1 (es)
BR (1) BR112014019585A8 (es)
CA (1) CA2864342A1 (es)
CL (1) CL2014002138A1 (es)
CO (1) CO7061084A2 (es)
EA (1) EA201491442A1 (es)
HK (1) HK1204433A1 (es)
IN (1) IN2014MN01671A (es)
MX (1) MX2014009693A (es)
PE (1) PE20142462A1 (es)
PH (1) PH12014501781A1 (es)
SG (1) SG11201404754TA (es)
TW (1) TW201339153A (es)
WO (1) WO2013123092A1 (es)
ZA (1) ZA201406740B (es)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20150023913A1 (en) 2013-07-02 2015-01-22 Bristol-Myers Squibb Company Hepatitis C Virus Inhibitors
US9717712B2 (en) 2013-07-02 2017-08-01 Bristol-Myers Squibb Company Combinations comprising tricyclohexadecahexaene derivatives for use in the treatment of hepatitis C virus
US9775831B2 (en) 2013-07-17 2017-10-03 Bristol-Myers Squibb Company Combinations comprising biphenyl derivatives for use in the treatment of HCV
TWI679203B (zh) 2014-06-11 2019-12-11 美商基利法瑪席特有限責任公司 製備抗病毒化合物之方法
ITUB20152784A1 (it) * 2015-08-03 2017-02-03 Chemelectiva S R L Processo per la sintesi di ravidasvir
US10617675B2 (en) 2015-08-06 2020-04-14 Bristol-Myers Squibb Company Hepatitis C virus inhibitors
CN109134439A (zh) * 2017-06-15 2019-01-04 歌礼生物科技(杭州)有限公司 丙肝治疗药物Ravidasvir的制备方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2438802A (en) * 2005-02-28 2007-12-05 Univ Rockefeller Structure of the hepatitis C virus NS5A protein
JP5762971B2 (ja) * 2008-12-03 2015-08-12 プレシディオ ファーマシューティカルズ インコーポレイテッド Hcvns5aの阻害剤
EP2400846B1 (en) * 2009-02-27 2016-10-05 Enanta Pharmaceuticals, Inc. Hepatitis c virus inhibitors
WO2011004276A1 (en) * 2009-07-06 2011-01-13 Pfizer Limited Hepatitis c virus inhibitors
UA108211C2 (uk) * 2009-11-04 2015-04-10 Янссен Рід Айрленд Бензімідазолімідазольні похідні
US9060971B2 (en) * 2010-03-04 2015-06-23 Enanta Pharmaceuticals, Inc. Combination pharmaceutical agents as inhibitors of HCV replication
US8877707B2 (en) * 2010-05-24 2014-11-04 Presidio Pharmaceuticals, Inc. Inhibitors of HCV NS5A

Also Published As

Publication number Publication date
MX2014009693A (es) 2014-09-08
SG11201404754TA (en) 2014-09-26
TW201339153A (zh) 2013-10-01
WO2013123092A1 (en) 2013-08-22
CA2864342A1 (en) 2013-08-22
AR093738A1 (es) 2015-06-24
BR112014019585A8 (pt) 2017-07-11
EP2814322A1 (en) 2014-12-24
IN2014MN01671A (es) 2015-05-29
CL2014002138A1 (es) 2014-11-28
PE20142462A1 (es) 2015-02-01
PH12014501781A1 (en) 2014-11-10
CN104219953A (zh) 2014-12-17
EP2814322A4 (en) 2015-09-23
BR112014019585A2 (es) 2017-06-20
KR20140145126A (ko) 2014-12-22
HK1204433A1 (en) 2015-11-20
AU2013221613A1 (en) 2014-09-04
EA201491442A1 (ru) 2015-01-30
JP2015506987A (ja) 2015-03-05
ZA201406740B (en) 2016-02-24
US20150203474A1 (en) 2015-07-23

Similar Documents

Publication Publication Date Title
CR20140259A (es) Compuestos novedosos de benzopirano, composiciones y usos de los mismos
CL2016000981A1 (es) Formulaciones de estrigolactona y sus usos
CR20150462A (es) Inhibidores de erk y sus usos
CL2014003136A1 (es) Nuevos diazaespirocicloalcanos y azaespirocicloalcanos; composicion farmaceutica que los contiene y usos.
CO7030961A2 (es) Benzotienilo-pirrolotriazinas disustituidas y sus usos
CL2016000251A1 (es) Anticuerpos anti-activina y usos de los mismos
CL2014002903A1 (es) Composición geopolimérica de aluminosilicato; método de preparacion y sus usos.
DK3594348T3 (da) Kort c/ebp-alpha til aktivering af rna-sammensætninger og anvendelsesfremgangsmåder
BR112015001838A2 (pt) composições de inibidor de efluxo e métodos de tratamento utilizando o mesmo.
DK2935303T3 (da) 4`-fluornukleosider, 4`-fluornukleotider og analoger dertil til behandling af HCV
CO6821892A2 (es) Anticuerpos anti-angptl3 y usos de los mismos
BR112015003227A2 (pt) processos de clicoconjugação e composições
CL2014002899A1 (es) Composiciones pesticidas y procesos relacionados con ellas
CO7020933A2 (es) Composiciones pesticidas y los procesos relacionados con las mismas
DK2920149T3 (da) 3-aminocycloalkyl-forbindelser som ror-gamma-t-inhibitorer og anvendelser deraf
BR112015003354A2 (pt) composições e métodos de microcápsula
CO7061084A2 (es) Formas sólidas que comprenden inhibidores de ns5a de hcv, sus composiciones y sus usos
CO6980627A2 (es) Anticuerpos anti-pfh-tau y sus usos
CO7061078A2 (es) Compuestos de enediino, conjugados de los mismos y sus usos y metodos
DK4082530T3 (da) Proteasehæmmerholdige sammensætninger, sammensætninger omfattende samme og fremgangsmåder til fremstilling og anvendelse af samme
CL2014002954A1 (es) Composicion farmaceutica que contiene anticuerpos anti-il-23p19 y sus usos.
CO6870031A2 (es) Pirrolotriazinas sustituidas con hidroximetilarilo y sus usos
CO6801713A2 (es) Heteroarilos y sus usos
BR112015009718A2 (pt) composição de matéria e artigo.
CO6950485A2 (es) Composiciones perfumantes y usos de las mismas